SAN FRANCISCO, CA / ACCESSWIRE / May 18, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today provided updates regarding the development program for the Company's oral ...
Crofelemer delayed-release tablets are Jaguar’s FDA-approved prescription drug under botanical guidance (“botanical drug”) derived from the Croton lechleri tree. Crofelemer, in a novel liquid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results